Cover Image
市場調查報告書

LondonPharma Ltd : 產品平台分析

LondonPharma Ltd - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 307312
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
LondonPharma Ltd : 產品平台分析 LondonPharma Ltd - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 23 Pages
簡介

LondonPharma Ltd 是開發舌下錠劑,致力於現有藥劑另作它用之生物製藥公司。該公司還有治療腫瘤,萊姆病,血吸蟲,勃起障礙,疼痛,成癮,噁心等各種產品之開發計劃。

本報告提供LondonPharma Ltd 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

LondonPharma Ltd的基本資料

  • LondonPharma Ltd概要
  • 主要資訊
  • 企業資料

LondonPharma Ltd:R&D概要

  • 主要的治療範圍

LondonPharma Ltd:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

LondonPharma Ltd:開發中產品概況

  • 最後階段的開發中產品
    • 第Ⅲ階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

LondonPharma Ltd:藥物簡介

  • artemether
  • 萊姆病小分子
  • 發炎性疾病小分子
  • 血吸蟲症轉動小分子

LondonPharma Ltd:開發平台分析

  • 各給藥途徑
  • 各分子類型

LondonPharma Ltd:最近的開發平台趨勢

LondonPharma Ltd:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07750CDB

Summary

Global Markets Direct's, 'LondonPharma Ltd - Product Pipeline Review - 2015', provides an overview of the LondonPharma Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of LondonPharma Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of LondonPharma Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of LondonPharma Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the LondonPharma Ltd's pipeline products

Reasons to buy

  • Evaluate LondonPharma Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of LondonPharma Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the LondonPharma Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of LondonPharma Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of LondonPharma Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of LondonPharma Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • LondonPharma Ltd Snapshot
    • LondonPharma Ltd Overview
    • Key Information
    • Key Facts
  • LondonPharma Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • LondonPharma Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • LondonPharma Ltd - Pipeline Products Glance
    • LondonPharma Ltd - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • LondonPharma Ltd - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • LondonPharma Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • LondonPharma Ltd - Drug Profiles
    • artemether
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Lyme Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Inflammation
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Schistosomiasis
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • LondonPharma Ltd - Pipeline Analysis
    • LondonPharma Ltd - Pipeline Products by Route of Administration
    • LondonPharma Ltd - Pipeline Products by Molecule Type
  • LondonPharma Ltd - Recent Pipeline Updates
  • LondonPharma Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • LondonPharma Ltd, Key Information
  • LondonPharma Ltd, Key Facts
  • LondonPharma Ltd - Pipeline by Indication, 2015
  • LondonPharma Ltd - Pipeline by Stage of Development, 2015
  • LondonPharma Ltd - Monotherapy Products in Pipeline, 2015
  • LondonPharma Ltd - Phase III, 2015
  • LondonPharma Ltd - Phase I, 2015
  • LondonPharma Ltd - Preclinical, 2015
  • LondonPharma Ltd - Pipeline by Route of Administration, 2015
  • LondonPharma Ltd - Pipeline by Molecule Type, 2015
  • LondonPharma Ltd - Recent Pipeline Updates, 2015

List of Figures

  • LondonPharma Ltd - Pipeline by Top 10 Indication, 2015
  • LondonPharma Ltd - Pipeline by Stage of Development, 2015
  • LondonPharma Ltd - Monotherapy Products in Pipeline, 2015
  • LondonPharma Ltd - Pipeline by Top 10 Route of Administration, 2015
  • LondonPharma Ltd - Pipeline by Top 10 Molecule Type, 2015
Back to Top